海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
334件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- A study to assess the long-term safety and efficacy of dupilumab administered in patients 6 to atopic dermatitis (eczema)
- Atopic dermatitis MedDRA version: 18.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Canada, Czech Republic, Germany, Hungary, Poland, United Kingdom
- 2015-06-25
Authorised
- A study to determine the effects of 8 week treatment with an oral drug called ZPL-3893787 in adult subjects with moderate to severe atopic dermatitis.
- Atopic Dermatitis (AD) MedDRA version: 18.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Belgium, Germany, Poland, United Kingdom
- 2015-02-04
Authorised
- A study to determine the safety and tolerability of REGN668 in patients aged =6 to atopic dermatitis (eczema)
- Atopic dermatits MedDRA version: 18.0 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858 ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- Canada, Czech Republic, Germany, Hungary, Poland, United Kingdom
- 2014-12-29
Authorised
- A study to investigate the effect of ANB020 or placebo in patients with moderate to severe Atopic Dermatitis when exposed to House Dust Mites.
- Atopic dermatitis MedDRA version: 19.0 Level: PT Classification code 10012438 Term: Dermatitis atopic System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]
- United Kingdom
- 2016-09-30
Authorised
- The added effect of oral ondansetron to care-as-usual on persisting vomiting in children aged 6 months to 6 years, presenting at primary care out of hours service with stomach flu and concomitant vomiting
- Gastroenteritis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06];Gastroenteritis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06];Gastroenteritis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Netherlands
- 2016-09-26
Authorised
- A randomized study to assess efficacy and safety of Anaceptrapib when added to ongoing lipid-lowering therapy.
- Heterozygous Familial Hypercholesterolemia;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Canada, Czech Republic, France, Germany, Netherlands, Norway, Russian Federation, Spain, United Kingdom, United States
- 2011-11-18
Authorised
- The benefit of adding drugs that stimulate the immune system to attack cancer to the standard treatment of colon cancer that has been removed surgically.
- Colon cancer stage III MedDRA version: 20.0 Level: LLT Classification code 10009949 Term: Colon cancer Duke's C System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- United Kingdom
- 2018-06-11
Authorised
- A study to determine the added value of vitamin D3 to treatment with subcutaneous immunotherapy in patients with birch pollen allergy
- subcutaneous immunotherapy in allergic rhinitis (AR) patients with allergies to birchpollen;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Netherlands
- 2018-06-07
Authorised
- RADIOCHEMIOTERAPIA CON TEMOZOLOMIDE CONCOMITANTE E ADIUVANTE NEL TRATTAMENTO DEI LINFOMI CEREBRALI PRIMITIVI DOPO METOTREXATE AD ALTE DOSI: STUDIO DI DOSE ESCALATION - ND
- primary central nervous lymphoma MedDRA version: 9.1 Level: HLGT Classification code 10025323 Term: Lymphomas NEC
- Italy
- 2008-04-09
Authorised
- Efficacy and safety comparison of CD4802 0.1% ointment versus vehicle in the treatment of target lesions in adults with atopic dermatitis
- Atopic Dermatitis MedDRA version: 9.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis
- France
- 2008-03-17